Testosterone-induced depression of adrenergic activity in the perfused canin hindlimb.
D000109:Acetylcholine / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D005260:Female; D005263:Femoral Artery; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006614:Hindlimb; D007269:Injections, Intra-Arterial; D007273:Injections, Intramuscular; D008297:Male; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010477:Perfusion; D013566:Sympathomimetics / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D013739:Testosterone / Q000008:administration & dosage / Q000494:pharmacology*; D014439:Tyramine / Q000037:antagonists & inhibitors; D014666:Vasomotor System / Q000187:drug effects
D013566:Sympathomimetics; D000804:Angiotensin II; D013739:Testosterone; D000109:Acetylcholine; D009638:Norepinephrine; D014439:Tyramine